Avanafil
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| FADB-China ID | C0575 |
| Substance Name | PDE-5 inhibitors drugs |
| Substance Chinese Name | PDE-5抑制剂药物 |
| Molecular Name | Avanafil |
| Molecular Chinese Name | 阿伐那菲 |
| 2D Structure | |
| CAS Number | 330784-47-9 |
| PubChem CID | 9869929 |
| Formula | C23H26ClN7O3 |
| IUPAC Name | 4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide |
| InChI Key | WEAJZXNPAWBCOA-INIZCTEOSA-N |
| InChI | InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1 |
| Canonical SMILES | COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCCC4CO)Cl |
| Isomeric SMILES | COC1=C(C=C(C=C1)CNC2=NC(=NC=C2C(=O)NCC3=NC=CC=N3)N4CCC[C@H]4CO)Cl |
| CFM-ID 3.0 | URL Link |
| Related links | Processing |
| Addition Purposes | Enhance health care function |
| Molecular Synonyms |
Avanafil
330784-47-9
STENDRA
TA 1790
TA-1790
UNII-DR5S136IVO
CHEBI:66876
DR5S136IVO
(S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine
(S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
|
| Data Uploader | Shuyu Ouyang |
| Update Date | Jul 25, 2019 20:46 |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 483.9 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 9 |
| Complexity | 642 |
| Monoisotopic Mass | 483.1785654 |
| Exact Mass | 483.1785654 |
| XLogP | 2.6 |
| Formal Charge | 0 |
| Heavy Atom Count | 34 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB- | 0.7165 |
| Human Intestinal Absorption | HIA+ | 0.9958 |
| Caco-2 Permeability | Caco2- | 0.6100 |
| P-glycoprotein Substrate | Substrate | 0.6720 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.6724 |
| Inhibitor | 0.9038 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5282 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.7566 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.7215 |
| CYP450 2D6 Substrate | Non-substrate | 0.7950 |
| CYP450 3A4 Substrate | Substrate | 0.6184 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5000 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.5841 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.7495 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5892 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.5490 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5277 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.6671 |
| Inhibitor | 0.8671 | |
| AMES Toxicity | Non AMES toxic | 0.6096 |
| Carcinogens | Non-carcinogens | 0.8809 |
| Fish Toxicity | High FHMT | 0.8114 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9671 |
| Honey Bee Toxicity | Low HBT | 0.8880 |
| Biodegradation | Not ready biodegradable | 0.9929 |
| Acute Oral Toxicity | III | 0.6560 |
| Carcinogenicity (Three-class) | Non-required | 0.5832 |
ADMET -- Regression
| Model | Value | Unit |
|---|---|---|
| Aqueous solubility | -3.6353 | LogS |
| Caco-2 Permeability | 0.8397 | LogPapp, cm/s |
| Rat Acute Toxicity | 2.5077 | LD50, mol/kg |
| Fish Toxicity | 1.4205 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 0.5354 | pIGC50, ug/L |
Related Foods
| FADB-China ID | F0142 |
| Food Image | ![]() |
| Food Name | Plant food supplements |
| Food Chinese Name | 植物食品补充剂 |
| Food Type | Processed food |
| References | Adulteration of Dietary Supplements by the Illegal Addition of Synthetic Drugs: A Review |
